BBIIBBLLIIOOGGRRAAFFIIAA
Bibliografia
44
Groves MD, Puduvalli VK, Hess KR, Jaeckle KA, Peterson P, Yung WKA, Levin VA (2002), Phase II Trial of Temozolomide Plus the Matrix Metalloproteinase Inhibitor, Marimastat, in Recurrent and Progressive Glioblastoma Multiforme. J Clinic Oncol 20:1383-1388
Nagase H, Woessner JF Jr (1999), Matrix metalloproteinases. J Biol Chem 274:21491-21494.
Nuttal RK, Pennington CJ, Taplin J, Wheal A, Yong VW, Forsyth PA, Edwards DR, (2003), Elevated Membrane-Type Matrix Metalloproteinases in Gliomas Revealed by Profiling Proteases and Inhibitors in Human Cancer Cell. Molecular cancer Research 1:333-345
Konstantinopoulos PA, Karamouzis MV, Papatsoris AG, Papavassiliou AG (2008), Matrix metalloproteinase inhibitors as anticancer agents. Int J Biochem Cell Biol 40:1156-1168.
Papi A, Bartolini G, Ammar K, Guerra F, Ferreri A.M., Rocchi P, Orlandi M, (2007), Inhibitory effects of retinoic acid and IIF on Growth, migration and Invasiveness in the U87MG human glioblastoma cell line. Oncol Reports 18:1015-1021
Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A (2005), N-i-Propoxy-N- biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP. Bioorg Med Chem Lett 15:1321- 1326.
